Donald Trump is trading defense stocks that surge with every strike on Iran. A filing with the Office of Government Ethics, reported this week by the Associated Press and detailed by The Main Street Independent, documents more than 3,600 buy and sell orders executed in a single quarter — a trading spree that tracks directly onto the levers of state power. The portfolio absorbed as much as $6 million in Nvidia after he approved the sale of its cutting-edge chips to China. He called Taiwan arms sales a “very good negotiating chip” with Beijing and simultaneously loaded up on Lockheed Martin, General Dynamics, and Northrop Grumman. These are not speculative bets placed in a vacuum. They are market positions aligned with an Iran escalation and a hardening defense posture.
In 1961, Dwight Eisenhower warned that a combination of the military establishment and a massive arms industry would acquire unwarranted influence, whether sought or unsought. The warning assumed a structural separation between policy formation and private capital accumulation. That separation has collapsed into a feedback loop. When the head of government treats arms sales and export controls as portfolio signals, the strategic calculus shifts from national defense to shareholder return. The military‑industrial complex no longer needs a lobbyist; it has a portfolio manager.
Andrew Bacevich’s Washington Rules (2010) tracks how the national‑security state externalized America’s wars while insulating the public from their cost, and Phil Klay’s Redeployment makes that cost excruciatingly personal, each medevac a line item on the side of a procurement invoice. Michael Walzer’s framework for just conflict draws a bright line between legitimate state action and private enrichment; the moment war policy becomes a market indicator, that line erodes. Trump’s trades complete a perverse loop: the commander in chief who sends soldiers into harm’s way also cashes in on the defense stocks that spike with every escalation. The supply lines of profit run straight from the White House to the brokerage account. Those of us who served in units that relied on those same contractors know what the Pentagon’s sole‑source contracts buy — and what they cost families in body bags and VA waiting rooms. The moral weight of a Lockheed share is not a hypothetical.
The procurement cycle — the multi‑year process of awarding contracts and moving money from the treasury to factory floors — stops serving as a legislative constraint and starts functioning as a personal yield curve. The appropriations line items do not remain abstract. They translate into rucksacks, body armor, and the actual distance between a deployed unit and its next engagement. The market treats those deployments as volatility. The soldiers carry them.
The Constitution demands a clean separation between state action and private accounts. Presidents in previous decades divested from conflict‑sensitive equities and surrendered individual security clearances precisely because the commingling of policy and profit destroys command legitimacy. A government that rewards the escalation it funds will always escalate.
The system he is using is the one a Republican and a Democratic Congress built, with an ethics regime that exempts the president from the conflict‑of‑interest statutes binding every Cabinet secretary. The 2012 STOCK Act extended insider‑trading coverage to the president on paper, but the 18 U.S.C. § 208 carve‑out for the president and vice president means the Oval Office trading desk sits in a law‑enforcement blind spot.
The ledger of war in 2026 now includes a president’s stock portfolio. None of the permanent‑war architecture — no‑bid contracting, cozy Pentagon‑industry ties — required a personal profit column. Trump has added it. The contracts will execute. The deployments will continue. The portfolio will adjust.